NL8801597A - 8alfa-acylaminoergolinen, werkwijzen voor de bereiding van deze verbindingen en farmaceutische preparaten die ze bevatten. - Google Patents

8alfa-acylaminoergolinen, werkwijzen voor de bereiding van deze verbindingen en farmaceutische preparaten die ze bevatten. Download PDF

Info

Publication number
NL8801597A
NL8801597A NL8801597A NL8801597A NL8801597A NL 8801597 A NL8801597 A NL 8801597A NL 8801597 A NL8801597 A NL 8801597A NL 8801597 A NL8801597 A NL 8801597A NL 8801597 A NL8801597 A NL 8801597A
Authority
NL
Netherlands
Prior art keywords
compound
formula
acid addition
addition salt
pharmaceutically acceptable
Prior art date
Application number
NL8801597A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8801597A publication Critical patent/NL8801597A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
NL8801597A 1987-06-23 1988-06-23 8alfa-acylaminoergolinen, werkwijzen voor de bereiding van deze verbindingen en farmaceutische preparaten die ze bevatten. NL8801597A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3720656 1987-06-23
DE3720656 1987-06-23

Publications (1)

Publication Number Publication Date
NL8801597A true NL8801597A (nl) 1989-01-16

Family

ID=6330087

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8801597A NL8801597A (nl) 1987-06-23 1988-06-23 8alfa-acylaminoergolinen, werkwijzen voor de bereiding van deze verbindingen en farmaceutische preparaten die ze bevatten.

Country Status (28)

Country Link
US (1) US5075318A (fr)
JP (1) JPH0670052B2 (fr)
KR (1) KR970001527B1 (fr)
AT (1) AT395242B (fr)
AU (1) AU615657B2 (fr)
BE (1) BE1004034A3 (fr)
CA (1) CA1302404C (fr)
CH (1) CH674646A5 (fr)
CY (1) CY1752A (fr)
DK (1) DK169335B1 (fr)
ES (1) ES2010282A6 (fr)
FI (1) FI88302C (fr)
FR (1) FR2617166B1 (fr)
GB (1) GB2206115B (fr)
GR (1) GR1002318B (fr)
HK (1) HK2794A (fr)
HU (2) HU203097B (fr)
IE (1) IE60550B1 (fr)
IL (1) IL86820A (fr)
IT (1) IT1219652B (fr)
LU (1) LU87251A1 (fr)
MY (1) MY103584A (fr)
NL (1) NL8801597A (fr)
NZ (1) NZ225112A (fr)
PH (1) PH24690A (fr)
PT (1) PT87781B (fr)
SE (1) SE467925B (fr)
ZA (1) ZA884505B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197569B (en) * 1984-01-12 1989-04-28 Sandoz Ag Process for producing 8alpha-acylaminoergoline derivatives and pharmaceuticals comprising such compounds
JP3630888B2 (ja) * 1996-10-31 2005-03-23 株式会社ニデック レンズ搬送装置と眼鏡レンズを搬送するための眼鏡レンズ用固定カップ及びレンズ搬送方法
BRPI0920246A2 (pt) 2008-10-17 2017-06-27 Winconsin Alumni Res Foundation método de preparação de alfa-beta peptídios biologicamente ativos.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197569B (en) * 1984-01-12 1989-04-28 Sandoz Ag Process for producing 8alpha-acylaminoergoline derivatives and pharmaceuticals comprising such compounds
NL8503426A (nl) * 1984-12-24 1986-07-16 Sandoz Ag 8alfa-acylamino-ergolinen, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten.

Also Published As

Publication number Publication date
IE881867L (en) 1988-12-23
FR2617166A1 (fr) 1988-12-30
HK2794A (en) 1994-01-21
AU1819488A (en) 1989-01-05
MY103584A (en) 1993-08-28
HU211651A9 (en) 1995-12-28
GR1002318B (el) 1996-05-13
FR2617166B1 (fr) 1992-07-17
GB2206115B (en) 1991-04-03
DK169335B1 (da) 1994-10-10
CA1302404C (fr) 1992-06-02
SE467925B (sv) 1992-10-05
KR890000479A (ko) 1989-03-14
JPS6422876A (en) 1989-01-25
JPH0670052B2 (ja) 1994-09-07
IE60550B1 (en) 1994-07-27
AU615657B2 (en) 1991-10-10
PH24690A (en) 1990-09-07
NZ225112A (en) 1991-03-26
AT395242B (de) 1992-10-27
IL86820A0 (en) 1988-11-30
IT8848097A0 (it) 1988-06-17
FI88302B (fi) 1993-01-15
ATA161788A (de) 1992-03-15
BE1004034A3 (fr) 1992-09-15
SE8802323D0 (sv) 1988-06-21
ZA884505B (en) 1990-02-28
HU203097B (en) 1991-05-28
US5075318A (en) 1991-12-24
GR880100401A (el) 1989-03-08
PT87781A (pt) 1989-05-31
HUT50174A (en) 1989-12-28
ES2010282A6 (es) 1989-11-01
FI883008A0 (fi) 1988-06-22
GB2206115A (en) 1988-12-29
IT1219652B (it) 1990-05-24
FI883008A (fi) 1988-12-24
FI88302C (fi) 1993-04-26
LU87251A1 (fr) 1989-03-08
CY1752A (en) 1994-06-03
IL86820A (en) 1991-07-18
SE8802323L (sv) 1988-12-24
KR970001527B1 (ko) 1997-02-11
CH674646A5 (fr) 1990-06-29
GB8814615D0 (en) 1988-07-27
PT87781B (pt) 1992-10-30
DK340188D0 (da) 1988-06-21
DK340188A (da) 1988-12-24

Similar Documents

Publication Publication Date Title
US6255490B1 (en) 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands
EP1425286B1 (fr) 7-aza-[2.2.1]-bicycloheptanes substitues pour le traitement de maladies
HU211575A9 (en) 2-methyl-thieno-benzodiazepine
NL8701682A (nl) Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten.
KR100492052B1 (ko) 인돌-2,3-디온-3-옥심유도체,이의제조방법및이를포함하는약제학적조성물
BRPI0708843A2 (pt) composto, composiÇço farmacÊutica, e, uso do composto
JP2002030084A (ja) １−アザビシクロアルカン化合物およびその医薬用途
ES2250345T3 (es) Derivados sustituidos de acido 1,2,3,4-tetrahidroquinolin-2-carboxilico.
BR122014023207A2 (pt) Compostos derivados de aza-adamantano, seus usos e processos para a preparação destes compostos
JP2022097655A (ja) 非ペプチドオキシトシン受容体アゴニスト
CN101641357A (zh) 4-取代的氮杂金刚烷衍生物及其使用方法
JPH0533709B2 (fr)
IE58883B1 (en) Nitrogen containing compounds
JP3253077B2 (ja) ヒドロイソキノリン誘導体
JP2009539865A (ja) 置換３−アミノ−チエノ［２，３−ｂ］ピリジン２−カルボン酸アミド化合物及び製造方法及びそれらの使用
US5696115A (en) Method for treating nicotine withdrawal
NL8801597A (nl) 8alfa-acylaminoergolinen, werkwijzen voor de bereiding van deze verbindingen en farmaceutische preparaten die ze bevatten.
KR20100125307A (ko) 니코틴성 아세틸콜린 수용체의 조절제로서 유용한 신규한 1,4-디아자-비사이클로[3.2.2]노닐 옥사디아졸릴 유도체
NO301227B1 (no) Arylsubstituerte, heterosykliske forbindelser, anvendelser derav og farmasöytisk preparat som omfatter en slik forbindelse
DK162050B (da) Pyrazolderivater med ergolinskelet eller salte deraf, deres fremstilling, farmaceutiske praeparater indeholdende disse og fremgangsmaade til fremstilling af de farmaceutiske praeparater
NZ556748A (en) Ocaperidone salts and pharmaceutical compositions containing the same
HU208077B (en) Process for producting pharmaceutical compositions against vomiting and nausea, comprising ergoline derivatives
EP0523013A2 (fr) Utilisation des dérivés de l'acide benzimidazoline-2-oxo-1-carboxylique dans le traitement des maladies mentales organiques
JPS62464A (ja) エルゴリン類および４−ジアルキルアミノテトラヒドロベンゾ〔ｃ，ｄ〕インド−ル類
HUT73438A (en) Quinoxalin-2,3-dione derivatives pericondensed with heterocycle

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: NOVARTIS AG

BN A decision not to publish the application has become irrevocable